Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Ultrasound Med Biol ; 25(7): 1069-76, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10574339

ABSTRACT

This study investigated the use of artificial neural networks (ANN) for image segmentation and spatial temporal contour linking for the detection of endocardial contours on echocardiographic images. Using a backpropagation network, the system was trained with 279 sample regions obtained from eight training images to segment images into either tissue or blood pool region. The ANN system was then applied to parasternal short axis images of 38 patients. Spatial temporal contour linking was performed on the segmented images to extract endocardial boarders. Left ventricular areas (end-systolic and end-diastolic) determined with the automated system were calculated and compared to results obtained by manual contour tracing performed by two independent investigators. In addition, ejection fractions (EF) were derived using the area-length method and compared with radionuclide ventriculography. Image quality was classified as good in 12 (32%), moderate in 13 (34%) and poor in 13 (34%) patients. The ANN system provided estimates of end-diastolic and end-systolic areas in 36 (89%) of echocardiograms, which correlated well with those obtained by manual tracing (R = 0.99, SEE = 1.44). A good agreement was also found for the comparison of EF between the ANN system and Tc-radionuclide ventriculography (RNV, R = 0.93, SEE = 6.36). The ANN system also performed well in the subset of patients with poor image quality. Endocardial contour detection using artificial neural networks and spatial temporal contour linking allows accurate calculations of ventricular areas from transthoracic echocardiograms and performs well even in images with poor quality. This system could greatly enhance the feasibility, accuracy and reproducibility of calculating cardiac areas to derive left ventricular volumes and ejection fractions.


Subject(s)
Echocardiography/instrumentation , Endocardium/diagnostic imaging , Image Processing, Computer-Assisted/instrumentation , Neural Networks, Computer , Ventricular Dysfunction, Left/diagnostic imaging , Ventricular Function, Left/physiology , Adult , Cardiac Volume/physiology , Diastole/physiology , Feasibility Studies , Female , Humans , Male , Sensitivity and Specificity , Stroke Volume/physiology , Systole/physiology , Ventricular Dysfunction, Left/physiopathology
2.
Ther Drug Monit ; 14(2): 125-31, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1585396

ABSTRACT

Various methods of gentamicin dosing were compared in order to evaluate factors that prevent achievement of therapeutic peak and trough plasma concentrations in every patient. When standard doses of 3 x 80 mg of gentamicin/day (i.e., 3 x 170 mumol/day) were administered, only 26% of peak and 51% of trough plasma concentrations were within the desired range. This percentage increased for peak levels to 54% (p less than 0.001) when physicians were instructed in the use of a programmed pocket calculator (PPC) and to 70% (p less than 0.001) when in addition the nursing staff was trained. The best results were achieved when dosing and blood sampling were supervised by a single trained person, 76% of initial peak and 71% of initial trough levels being within the therapeutic range. In this group of patients, further dosage adjustments by the PPC achieved 92% of peak levels in the desired range, while no patient had elevated trough levels. Analysis of the factors that led to these results revealed that neither the laboratory nor the PPC are limiting factors for optimal results. The goal of therapeutic plasma concentrations can be achieved, but requires appropriate attention to the accuracy of blood sampling and dosing. For this purpose, a special program, i.e., more than ordinary attention to drug therapy, is needed.


Subject(s)
Computers , Gentamicins/administration & dosage , Adolescent , Adult , Aged , Aged, 80 and over , Female , Gentamicins/pharmacokinetics , Half-Life , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL